|
Star Lake Bioscience Co., Inc.zhaoqing Guangdong (600866.SS) Évaluation DCF |
Entièrement Modifiable: Adapté À Vos Besoins Dans Excel Ou Sheets
Conception Professionnelle: Modèles Fiables Et Conformes Aux Normes Du Secteur
Pré-Construits Pour Une Utilisation Rapide Et Efficace
Compatible MAC/PC, entièrement débloqué
Aucune Expertise N'Est Requise; Facile À Suivre
Star Lake Bioscience Co., Inc.Zhaoqing Guangdong (600866.SS) Bundle
Gardez un aperçu de votre analyse d'évaluation Star Lake Bioscience Co., Inc. (600866SS) à l'aide de notre calculatrice DCF de pointe! Préchargé avec des données réelles (600866SS), ce modèle Excel vous permet d'ajuster les prévisions et les hypothèses pour déterminer avec précision la valeur intrinsèque de Star Lake Bioscience Co., Inc.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2020 |
AY2 2021 |
AY3 2022 |
AY4 2023 |
AY5 2024 |
FY1 2025 |
FY2 2026 |
FY3 2027 |
FY4 2028 |
FY5 2029 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1,116.3 | 1,235.0 | 17,486.3 | 17,281.4 | 17,334.4 | 22,091.6 | 28,154.4 | 35,880.9 | 45,728.0 | 58,277.4 |
| Revenue Growth, % | 0 | 10.64 | 1315.84 | -1.17 | 0.3066 | 27.44 | 27.44 | 27.44 | 27.44 | 27.44 |
| EBITDA | 259.2 | 396.6 | 2,674.5 | 1,901.0 | 2,189.1 | 4,164.5 | 5,307.4 | 6,763.9 | 8,620.2 | 10,985.9 |
| EBITDA, % | 23.22 | 32.11 | 15.29 | 11 | 12.63 | 18.85 | 18.85 | 18.85 | 18.85 | 18.85 |
| Depreciation | 88.5 | 299.6 | 983.2 | 853.5 | 846.3 | 2,104.6 | 2,682.2 | 3,418.3 | 4,356.4 | 5,551.9 |
| Depreciation, % | 7.93 | 24.26 | 5.62 | 4.94 | 4.88 | 9.53 | 9.53 | 9.53 | 9.53 | 9.53 |
| EBIT | 170.7 | 97.0 | 1,691.2 | 1,047.5 | 1,342.8 | 2,059.9 | 2,625.2 | 3,345.7 | 4,263.8 | 5,434.0 |
| EBIT, % | 15.29 | 7.85 | 9.67 | 6.06 | 7.75 | 9.32 | 9.32 | 9.32 | 9.32 | 9.32 |
| Total Cash | 232.6 | 231.0 | 1,373.8 | 1,425.0 | 1,909.7 | 2,945.1 | 3,753.4 | 4,783.5 | 6,096.2 | 7,769.3 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 210.7 | 3,229.5 | 821.3 | 1,060.4 | 1,049.8 | 5,998.5 | 7,644.7 | 9,742.7 | 12,416.5 | 15,824.0 |
| Account Receivables, % | 18.88 | 261.49 | 4.7 | 6.14 | 6.06 | 27.15 | 27.15 | 27.15 | 27.15 | 27.15 |
| Inventories | 245.7 | 279.5 | 3,328.7 | 2,305.4 | 2,074.6 | 3,931.8 | 5,010.8 | 6,386.0 | 8,138.5 | 10,372.1 |
| Inventories, % | 22.02 | 22.63 | 19.04 | 13.34 | 11.97 | 17.8 | 17.8 | 17.8 | 17.8 | 17.8 |
| Accounts Payable | 224.8 | 2,329.5 | 1,845.8 | 779.1 | 1,256.9 | 6,294.0 | 8,021.2 | 10,222.6 | 13,028.0 | 16,603.4 |
| Accounts Payable, % | 20.14 | 188.62 | 10.56 | 4.51 | 7.25 | 28.49 | 28.49 | 28.49 | 28.49 | 28.49 |
| Capital Expenditure | -289.9 | -205.1 | -452.3 | -375.8 | -638.5 | -2,254.2 | -2,872.8 | -3,661.3 | -4,666.0 | -5,946.6 |
| Capital Expenditure, % | -25.97 | -16.61 | -2.59 | -2.17 | -3.68 | -10.2 | -10.2 | -10.2 | -10.2 | -10.2 |
| Tax Rate, % | 23.51 | 23.51 | 23.51 | 23.51 | 23.51 | 23.51 | 23.51 | 23.51 | 23.51 | 23.51 |
| EBITAT | 162.1 | 93.4 | 1,405.4 | 822.3 | 1,027.0 | 1,769.0 | 2,254.5 | 2,873.2 | 3,661.7 | 4,666.6 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -271.0 | -759.8 | 811.5 | 1,017.6 | 1,954.0 | -149.5 | 1,065.9 | 1,358.4 | 1,731.2 | 2,206.2 |
| WACC, % | 5.15 | 5.16 | 5.06 | 5.02 | 5.01 | 5.08 | 5.08 | 5.08 | 5.08 | 5.08 |
| PV UFCF | ||||||||||
| SUM PV UFCF | 5,135.7 | |||||||||
| Long Term Growth Rate, % | 1.00 | |||||||||
| Free cash flow (T + 1) | 2,228 | |||||||||
| Terminal Value | 54,608 | |||||||||
| Present Terminal Value | 42,623 | |||||||||
| Enterprise Value | 47,759 | |||||||||
| Net Debt | 1,011 | |||||||||
| Equity Value | 46,748 | |||||||||
| Diluted Shares Outstanding, MM | 1,661 | |||||||||
| Equity Value Per Share | 28.14 |
What You Will Receive
- Customizable Excel Template: An adaptable Excel-based DCF Calculator featuring pre-filled financial data for Star Lake Bioscience Co., Inc. (600866SS).
- Valuable Data: Access to historical performance metrics and forward-looking projections (highlighted in the yellow cells).
- Flexible Forecasting: Adjust key assumptions such as revenue growth, EBITDA %, and WACC easily.
- Instant Calculations: View the effects of your inputs on the valuation of Star Lake Bioscience Co., Inc. (600866SS) in real time.
- Professional Resource: Designed for investors, CFOs, consultants, and financial analysts in the biotech sector.
- Intuitive Interface: Organized for ease of understanding and efficiency, complete with step-by-step guidance.
Core Advantages
- Authentic Financial Data: Gain access to reliable pre-loaded historical figures and future forecasts for Star Lake Bioscience Co., Inc. (600866SS).
- Adjustable Forecast Parameters: Modify highlighted cells for discount rates, growth metrics, and profit margins.
- Real-Time Calculations: Automatic adjustments for DCF, Net Present Value (NPV), and cash flow assessments.
- Interactive Dashboard: User-friendly charts and summaries to effectively illustrate your valuation insights.
- Accessible for All Levels: A straightforward, intuitive design tailored for investors, CFOs, and consultants alike.
How It Works
- Step 1: Download the Excel file.
- Step 2: Review the pre-filled Star Lake Bioscience data (historical and projected).
- Step 3: Modify key assumptions (yellow cells) based on your insights.
- Step 4: Observe automatic recalculations for Star Lake Bioscience's intrinsic value.
- Step 5: Utilize the results for investment decisions or reporting.
Why Choose This Calculator for Star Lake Bioscience Co., Inc. (600866SS)?
- Reliable Data: Utilize the latest financials from Star Lake Bioscience for trustworthy valuation outcomes.
- Tailored Inputs: Modify critical factors such as growth projections, WACC, and tax rates to align with your forecasts.
- Efficiency Boost: Built-in calculations help you save time and avoid starting from zero.
- Industry-Standard Tool: Crafted for investors, analysts, and consultants in the biotech sector.
- Easy to Use: User-friendly design with straightforward guidance ensures accessibility for everyone.
Who Should Use This Product?
- Individual Investors: Gain insights to make informed decisions about buying or selling Star Lake Bioscience Co., Inc. (600866SS) stock.
- Financial Analysts: Enhance valuation processes with comprehensive financial models tailored for biotechnology firms.
- Consultants: Provide clients with accurate and timely valuation insights for companies like Star Lake Bioscience Co., Inc. (600866SS).
- Business Owners: Learn about the valuation methods applied to leading biotech companies to refine your own business strategy.
- Finance Students: Explore valuation techniques through the lens of real-world data and case studies from the biotechnology sector.
Contents of the Template
- In-Depth DCF Model: An editable template featuring comprehensive valuation calculations.
- Actual Data: Historical and projected financials for Star Lake Bioscience Co., Inc. (600866SS) are preloaded for evaluation.
- Adjustable Parameters: Modify WACC, growth rates, and tax assumptions to explore different scenarios.
- Complete Financial Statements: Detailed annual and quarterly financial breakdowns for enhanced analysis.
- Essential Ratios: Integrated analysis covering profitability, efficiency, and leverage metrics.
- Visual Dashboard: A collection of charts and tables to present clear and actionable insights.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.